Change in Directorate

Based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors at its meeting held on 30th May, 2019 has decided to appoint Dr. Ravi Kumar Bansal (DIN:08462513) as an Additional Director (Independent) of the Company for a period of 5 years with immediate effect subject to the approval of shareholders in the ensuing General Meeting.


© Medicamen Biotech Limited. All Rights Reserved.

website designed & developed by Blue Moon Technologies.